Skip to content

Advertisement

  • Research note
  • Open Access

Bacteriological profile of neonatal sepsis and antibiotic susceptibility pattern of isolates admitted at Kanti Children’s Hospital, Kathmandu, Nepal

  • 1Email author,
  • 2,
  • 3Email author,
  • 4,
  • 4,
  • 5 and
  • 1
BMC Research Notes201811:301

https://doi.org/10.1186/s13104-018-3394-6

  • Received: 16 February 2018
  • Accepted: 3 May 2018
  • Published:

Abstract

Objective

Neonatal sepsis is a major cause of morbidity and mortality of newborns (< 1 month of age). Septicemia and drug resistance is a predominant issue for neonatal death in Nepal. This study is intended to find bacteriological profile of neonatal sepsis and antibiotic susceptibility pattern of the isolates from neonates at Kanti Children’s Hospital, Kathmandu, Nepal.

Results

Out of 350 suspected cases of neonatal sepsis, 59 (16.9%) cases showed positive blood culture. The prevalent of positive blood culture with different neonatal risk factors (sex, age, birth weight, gestational age, and delivery mode) showed highest positive bacterial growth in male (52.3%); 3 or above 3 days age (71.2%); low birth weight (62.7%); preterm gestational age (31.4%); and caesarean delivery mode (63.3%). Among positive cases, the bacteriological profile was found highest for Staphylococcus aureus (35.6%) followed by Klebsiella pneumoniae (15.3%). The most sensitive and resistive antibiotics among Gram-positive isolates were gentamicin (93%) and ampicillin (78%), respectively. Meropenem and imipenem showed highest 100% effective and cefotaxime was least (28%) sensitive among Gram-negative isolates. This concludes broad ranges of bacteria are associated with neonatal sepsis and revealed variation in antibiotic susceptibility pattern among bacterial isolates.

Keywords

  • Neonatal sepsis
  • Bacteriological profile
  • Antibiotic susceptibility
  • Neonates

Introduction

Neonatal sepsis is a clinical syndrome (sepsis neonatorum) resulting from the pathophysiologic effects of local or systemic infection. It affects newborns below 1 month of age and encompasses systemic infections including meningitis, pneumonia, arthritis, osteomyelitis and urinary tract infections [1, 2]. Neonates are immune-compromised and defend weakly to bacterial infections. The bacterial agents associated with neonatal sepsis are Group B Streptococci, Escherichia coli, Listeria monocytogenes, coagulase-negative Staphylococci (CoNS), Staphylococcus aureus, Enterococci, Klebsiella spp., Enterobacter spp., Pseudomonas spp., Salmonella spp., H. influenzae, Neisseria meningitidis, and Streptococcus pneumoniae [35].

In developing countries, unsafe birthing practices have critical role to cause neonatal infections. Globally, the neonatal morbidity and mortality cases have been estimated to 2.5–3 million, annually [6]. Neonatal mortality rate (NMR) distribution disparities can be seen based on socioeconomic, educational and geographical parameters. In Nepal, neonatal mortality has been found due to septicemia and emergence of drug resistant bacteria. According to Nepal Demographic and Health Survey (2011), 85% of total death is accounted to neonatal sepsis which is higher than previous surveys, 70% in 2006 and 69% in 2001 [7]. NMR is higher in rural areas (34 deaths per 1000 live births) than in urban areas (23 deaths per 1000 live births). Currently, emergence of multidrug resistant bacteria imposes challenges in treatment of neonatal sepsis [8, 9]. Therefore, the knowledge of prevalence of local isolates and their antimicrobial sensitivity pattern is of utmost necessary for prompt antimicrobial therapy of neonatal sepsis. This study aims to determine incidence and bacteriological profile of neonatal sepsis in relation to neonatal risk factors (sex, age, birth weight, gestational age, and mode of delivery) along with antibiotic susceptibility pattern of the isolates from neonates admitted in neonatal intensive care unit of Kanti Children’s Hospital, Kathmandu, Nepal.

Main text

This hospital based cross-sectional study was conducted in Microbiology Laboratory of Kanti Children’s Hospital, Kathmandu, Nepal from April to September 2015. Sample size was determined based on prevalence rate of previous study [8]. A total of 350 suspected cases of neonatal sepsis were included in this study. The diagnosis of neonatal sepsis was based on clinical profile, septic screening, and blood culture.

Methodology

The blood samples (1–2 ml) were collected from suspected neonates following standard aseptic techniques and inoculated directly into brain heart infusion (BHI; HiMedia, M210) broth containing blood in a ratio of (1:5). The culture bottles were incubated immediately at 37 °C for 5–7 days and were examined daily for growth and turbidity, hemolysis of red cells, gas bubbles and clot formation of discrete colonies. This helps in the presumptive diagnosis of positive broth culture. After incubation, subcultured from BHI broth was performed on blood agar (BA; HiMedia, M073) and MacConkey agar (MA; HiMedia, M081). The MA plates were incubated aerobically and BA plates were incubated anaerobically using BBL anaerobic jar with a GasPak™ EZ Gas Generating Container (Becton–Dickinson) at 37 °C for 24 h. The pure isolates obtained from subcultured plates were identified by following standard microbiological techniques which include studies of colony morphology, Gram-staining reactions and various biochemical properties (catalase and oxidase tests, slide and tube coagulase tests, SIM, MRVP, citrate, triple sugar iron, urease tests) [911].

Antibiotic susceptibility test of isolates was performed by modified Kirby-bauer disk diffusion method according to guidelines of Clinical and Laboratory Standards Institute (CLSI) [12]. The antibiotics used in this study were ampicillin (10 µg), amoxycillin (30 µg), piperacillin (100 µg), amikacin (30 µg), gentamicin (10 µg), azithromycin (30 µg), cefotaxime (30 µg), ceftazidime (30 µg), ciprofloxacin (5 µg), ofloxacin (5 µg), cotrimoxazole (25 µg), erythromycin (15 µg), meropenem (10 µg), and imipenem (10 µg). All the antibiotic discs used for susceptibility test were purchased from Himedia, India. For biochemical tests and antibiotics sensitivity tests, following reference strains were used for quality control: E. coli ATCC 25922; Pseudomonas aeruginosa ATCC 27853; Klebsiella pneumoniae ATCC 700603; Salmonella typhimurium ATCC 14028; and Staphylococcus aureus ATCC25923.

All the data were entered in the worksheet of SPSS software version (16.0) and Chi square test was performed. P value was calculated and considered significant only when it was less than or equal to 0.05.

Results

Out of 350 blood samples, 59 samples showed growth of organism and 291 samples did not show any microbial growth. The incidence of neonatal sepsis was 16.9% among 350 blood samples enrolled in this study. Among positive cases, the bacteriological profile showed 27 (46%) were Gram-positive cocci and 32 (54%) were Gram-negative bacilli. The highest bacterial strains isolated were S. aureus (35.6%) followed by K. pneumoniae (15.3%), Acinetobacter spp. (11.9%), Enterobacter spp. (10.2%), CoNS (10.2%), P. aeruginosa (6.8%), E. coli (6.8%), Citrobacter spp. (1.7%), and S. typhi (1.7%) (Fig. 1). The highest prevalence (52.3%) of positive blood culture was found in the male neonates. There was no significant association between gender and blood culture positivity (P > 0.05). In relation to different neonatal risk factors, positive blood culture showed the highest prevalence of bacterial growth in neonatal cases with 3 or above 3 days age (71.2%); low birth weight (62.7%); preterm gestational age (31.4%); and caesarean mode of delivery (63.3%). Statistical analysis showed that there was significant association between neonatal risk and culture positivity among suspected cases (P < 0.05) (Table 1).
Fig. 1
Fig. 1

Bacteriological profile of neonatal sepsis from suspected neonates

Table 1

Prevalence of positive blood culture in relation to different neonatal risk factors

S. no.

Neonatal risk factors

Culture positive (%)

Culture negative (%)

p value

1

Sex

> 0.05

 Male

31 (52.3)

173 (59.5)

 Female

28 (47.4)

118 (40.5)

2

Age

< 0.05

 Below 3 days

17 (28.8)

35 (12.0)

 3 or above 3 days

42 (71.2)

256 (88.0)

3

Birth weight

< 0.05

 Very low birth weight

2 (3.9)

1 (0.3)

 Low birth wight

37 (62.7)

50 (17.2)

 Good birth weight

20 (33.9)

240 (82.5)

4

Gestational age

< 0.05

 Preterm

22 (31.4)

48 (68.6)

 Term

37 (13.2)

243 (86.7)

5

Mode of delivery

< 0.05

 Normal

21 (7.2)

269 (92.3)

 Caesarean

38 (63.3)

22 (36.7)

The most effective antibiotic against Gram-positive bacteria was found to be gentamicin (93%) followed by amikacin (89%) and ofloxacin (85%). The least effective drugs were erythromycin (52%) and cefotaxime (63%). Ampicillin showed the highest resistivity 78% among Gram-positive and 91% among Gram-negative isolates (Table 2). Gentamicin (90%) and ofloxacin (90%) were the most sensitive and ampicillin (76%) was the most resistive antibiotics against S. aureus. All the CoNS strains were sensitive towards amikacin and gentamicin. Ampicillin and ciprofloxacin showed the highest resistance (83%, each) among CoNS isolates. Among K. pneumoniae isolates, amikacin, gentamicin, meropenem, and imipenem were found to be 100% sensitive; and ampicillin, cefotaxime, and ceftazidime were found to be 100% resistive. Piperacillin was the most effective against all Acinetobacter and P. aeruginosa isolates. Ampicillin was 100% resistant to Acinetobacter strains and amoxycillin and cotrimoxazole was ineffective to all isolates of P. aeruginosa. Meropenem, imipenem, gentamicin, and amikacin were effective antibiotics against all the isolates of Enterobacter. None of the strain of Enterobacter showed sensitive towards amoxycillin. Ofloxacin, gentamicin, and amikacin were 100% susceptible against E. coli, whereas amoxycillin was resistant towards all E. coli isolates. Ceftazidime, amikacin, gentamicin, and ofloxacin were the most sensitive antibiotics against Citrobacter and S. typhi isolates. But, Ampicillin and cotrimoxazole showed 100% resistivity against Citrobacter and S. typhi isolates (Table 2).
Table 2

Antimicrobial susceptibility patterns of bacterial strains isolated from suspected cases of neonatal sepsis

Antibiotics

K. pneumonia n = 9 (%)

Acinetobacter spp. n = 7 (%)

Enterobacter spp. n = 6 (%)

P. aeruginosa n = 4 (%)

E. coli n = 4 (%)

Citrobacter spp. n = 1 (%)

S. typhi n = 1 (%)

S. aureus n = 21 (%)

CoNS n = 6 (%)

Ampicillin

0

0

NT

NT

2 (50)

0

0

5 (24)

1 (17)

Amoxycillin

5 (36)

2 (29)

0

0

0

0

1 (100)

16 (76)

3 (50)

Piperacillin

NT

7 (100)

NT

4 (100)

NT

NT

NT

NT

NT

Amikacin

9 (100)

4 (57)

6 (100)

2 (50)

4 (100)

1 (100)

1 (100)

18 (86)

6 (100)

Gentamicin

9 (100)

3 (43)

6 (100)

3 (75)

4 (100)

1 (100)

1 (100)

19 (90)

6 (100)

Azithromycin

NT

NT

NT

NT

NT

NT

1 (100)

NT

NT

Cefotaxime

0

3 (43)

1 (17)

2 (50)

2 (50)

0

1 (100)

12 (57)

5 (83)

Ceftazidime

0

1 (14)

2 (33)

2 (50)

2 (50)

1 (100)

1 (100)

NT

NT

Ciprofloxacin

5 (56)

1 (14)

1 (17)

2 (50)

3 (75)

0

1 (100)

18 (86)

1 (17)

Ofloxacin

7 (78)

4 (57)

5 (83)

3 (75)

4 (100)

1 (100)

1 (100)

19 (90)

4 (67)

Cotrimoxazole

1 (11)

5 (71)

5 (83)

0

3 (75)

0

0

NT

NT

Erythromycin

NT

NT

NT

NT

NT

NT

NT

9 (43)

5 (83)

Meropenem

9 (100)

NT

6 (100)

NT

NT

1 (100)

NT

NT

NT

Imipenem

9 (100)

NT

6 (100)

NT

NT

1 (100)

NT

NT

NT

Discussion

Neonatal bacterial sepsis is a major cause of death in developing countries like Nepal. The emergence of antibiotics resistant bacteria and its dissemination is exacerbated by inappropriate antimicrobial consumption and precarious living condition. The most common organisms associated with neonatal sepsis vary with time of infections and geographical location [8]. Therefore, information on bacteriological profile of neonatal sepsis and effective antimicrobials for its treatment are important to combat with neonatal morbidity and mortality issues.

This study found 16.9% of neonates had microbiologically confirmed sepsis. The incidence rate of this study is quite lower compared to previous studies which have reported the incidence rate above 40% [8, 13]. The low incidence rate is due to the fact that this study was conducted in tertiary care hospital where most of the cases were referred from other hospital and clinics. Most of these referred cases had the history of antibiotics therapy prior to referral. The finding of prevalence of positive blood culture in relation to different neonatal risk factors can be useful to determine the preventive measures for neonatal sepsis (Table 1). The higher rate of growth positivity was observed in male compared to female neonates. These finding is in agreement with previous studies [1416]. The prevalence of positive blood culture was found to be higher in 3 or above 3 days of age (late onset of sepsis) compared to below 3 days of age (early onset of sepsis). Most of the previous studies have shown similar pattern of high prevalence of neonatal sepsis in late onset of sepsis [9, 17]. Prolonged use of invasive ventilator and catheter, failure of early breast feeding, longer use of parenteral nutrition, hospitalization, surgery, cardiovascular diseases, and respiratory infections lead to late onset of sepsis among neonates [18, 19]. Positive blood culture was observed high (62.7%) in low birth weight neonates. The low birth weight is strong neonatal risk factor that leads to cause neonatal sepsis [14]. This study showed highest infection among preterm neonates compared to term neonates. The most predisposing factors of infection in neonates are premature birth and low birth weight. Preterm neonates have 3 to tenfold higher incidence of infections than full term normal birth weight infants [6]. The neonates delivered by caesarean section showed the highest positive blood culture compared to normal deliver. Studies have revealed increased risk of neonatal death delivered by caesarean compared to vaginal delivery [20].

The bacterial profile revealed the highest prevalence of S. aureus followed by K. pneumoniae Acinetobacter spp., Enterobacter spp., CoNS, P. aeruginosa, E. coli, Citrobacter spp., and S. typhi (Fig. 1). These bacterial strains are predominant causative agents which have been identified by several studies [8, 9, 11, 13, 15]. This study has shown the frequency of isolation of Gram-negative bacteria was higher compared to Gram-positive bacteria. The causative organism varies due to geographical area. Neonates have high chance to acquire large proportion of vaginal Gram-negative bacteria [8]. Among the Gram-positive isolates, S. aureus is predominant hospital acquired organism. Furthermore, S. aureus has greater chance of transmission from health care workers and relatives to neonates [21]. Among Gram-negative isolates, K. pneumoniae accounts the highest which causes infection in neonates. This finding was similar with previous studies conducted among neonates [22, 23].

The antibiotic susceptibility pattern of bacterial isolates from blood culture showed the maximum susceptibility towards amikacin, gentamicin, ciprofloxacin, and ofloxacin. However, the isolates showed the higher resistivity pattern towards ampicillin and amoxycillin. The most effective antibiotics against predominant isolates S. aureus and other CoNS isolates were amikacin, gentamicin, ciprofloxacin, and ofloxacin. For K. pneumoniae and other Gram-negative strains, meropenem, imipenem, amikacin, gentamicin, ciprofloxacin, and ofloxacin were drug of choice for treatment of neonatal sepsis. The antibiotic sensitivity test of bacterial strains isolated from this study provides insight for selection of appropriate drugs for further control of neonatal mortality rate. Ampicillin and amoxycillin which have been revealed as ineffective drugs might be due to emergence of antimicrobial genes in bacteria and inappropriate use of antibiotics prior to hospitalization of neonatal cases [8, 13].

In overall, neonatal septicemia is a life threatening emergency and its rapid treatment with antibiotics is essential. The knowledge of the etiological organisms of neonatal sepsis and their antibiotic susceptibility profile is necessary for effective therapeutic intervention. It is therefore important to note that commencement of empirical antibiotic therapy is of essence while awaiting blood culture result. The initial empiric antibiotic use must therefore be a combination of drugs to cover for the prevalent bacterial organisms in that locality.

Conclusions

This study showed the high prevalence of S. aureus as Gram-positive bacteria and K. pneumoniae as Gram-negative bacteria among suspected neonatal cases. Overall isolates showed maximum sensitivity towards aminoglycosides and quinolones whereas minimum sensitivity towards penicillin. In Nepal, emergence of antibiotic resistance among bacterial isolates from neonatal sepsis is a major cause for treatment failure, higher morbidity and mortality. Proper antibiotic guidelines and its effective implementation could be milestone for revolution in the field of antibiotic resistance control. The epidemiology of neonatal sepsis, causative risk factors and antibiotic resistance pattern of pathogens may be used to develop guidelines for management of neonatal sepsis.

Limitations

This study has enrolled neonates which were only admitted to Kanti Children’s Hospital, Nepal. Future research should covered suspected neonates from different part of Nepal to determine overall neonatal prevalence of the country.

Abbreviations

BA: 

blood agar

CLSI: 

Clinical and Laboratory Standards Institute

CoNS: 

coagulase-negative Staphylococci

MA: 

MacConkey agar

MRVP: 

methyl-red, Voges Proskauer

SIM: 

sulfide, indole, motility

Declarations

Authors’ contributions

NSY, SS, and PKM conceived the concept and design of this study and performed experimental work. NSY, PP1, PP2, AS, and DKC analyzed the data and prepared the final draft of the manuscript. All authors read and approved the final manuscript.

Acknowledgements

This work was submitted to the St. Xavier’s College, Tribhuvan University, Kathmandu, Nepal, by Nikita Singh Yadav, in partial fulfillment of the requirement for the award of degree of Master of Science in Microbiology (Medical). We acknowledge to all the faculty members of Department of Microbiology, St. Xavier’s College and technical staffs of Kanti Children’s Hospital, Maharajgunj.

Competing interests

The authors declare that they have no competing interests.

Availability of data and materials

All data obtained during this study are available within the article.

Consent for publication

Not applicable.

Ethical approval and consent to participate

Ethical approval (Ref no. 1048) was obtained from Institutional Review Committee (IRC) of Kanti Children’s Hospital, Kathmandu, Nepal before conducting the research. The study protocol was verified by Research Committee of Kanti Children’s Hospital and Microbiology Department of St. Xavier’s College, Kathmandu, Nepal. Informed written consent was obtained from parent of each participant involved in this study.

Funding

No specific funding for this study was received.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Microbiology, St. Xavier’s College, Kathmandu, Nepal
(2)
Kanti Children’s Hospital, Maharajgunj, Nepal
(3)
Department of Microbiology, Prithu Technical College, Institute of Agriculture and Animal Science, Tribhuvan University, Dang, Nepal
(4)
Department of Microbiology, National College, Kathmandu, Nepal
(5)
Department of Microbiology, Balkumari College, Chitwan, Nepal

References

  1. Vergnano S, Sharland M, Kazembe P, Mwansambo C, Heath PT. Neonatal sepsis: an international perspective. Arch Dis Child Fetal Neonatal Ed. 2005;90:F220–4.View ArticlePubMedPubMed CentralGoogle Scholar
  2. Haque KN. Defining common infections in children and neonates. J Hosp Infect. 2007;2007(65):110–4.View ArticleGoogle Scholar
  3. Arora U, Devi P. Bacterial profile of blood stream infections and antibiotic resistant pattern of isolates. JK Sci. 2007;9:186–90.Google Scholar
  4. Zakariya BP, Bhat V, Harish BN, Arun Babu T, Joseph NM. Neonatal sepsis in a tertiary care hospital in South India: bacteriological profile and antibiotic sensitivity pattern. Indian J Pediatr. 2011;78:413–7.View ArticlePubMedGoogle Scholar
  5. Camacho-Gonzalez A, Spearman PW, Stoll BJ. Neonatal infectious diseases: evaluation of neonatal sepsis. Pediatr Clin N Am. 2013;60:367–89.View ArticleGoogle Scholar
  6. Darmstadt GL, Zaidi AKM, Stoll BJ. Neonatal infections: a global perspective. In: Infectious diseases of the fetus and newborn infant. Philadelphia: Elsevier; 2011. p. 24–51.View ArticleGoogle Scholar
  7. Ministry of Health and Population (MOHP) [Nepal], New ERA, and ICF International Inc. Nepal Demographic and Health Survey. Kathmandu: Ministry of Health and Population, New ERA, and ICF International; 2011. p. 2012.Google Scholar
  8. Shrestha RK, Rai SK, Khanal LK, Mandal PK. Bacteriological study of neonatal sepsis and antibiotic susceptibility pattern in Kathmandu, Nepal. Nepal Med Coll J. 2013;15:71–3.PubMedGoogle Scholar
  9. Shrestha NJ, Subedi KU, Rai GK. Bacteriological profile of neonatal sepsis: a hospital based study. J Nep Paedtr Soc. 2011;31:1–5.Google Scholar
  10. Mackie TJ, McCartney JE. Practical medical microbiology. 14th ed. New York: Churchill Livingstone; 1996.Google Scholar
  11. Kumhar GD, Ramachandran VG, Gupta P. Bacteriological analysis of blood culture isolates from neonates in a tertiary care hospital in India. J Health Popul Nutr. 2002;20:343–7.PubMedGoogle Scholar
  12. Clinical Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. In: 24th informational supplement (M100-S23) CLSI, Wayne PA, USA; 2014.Google Scholar
  13. Shaw CK, Shaw CP, Thapalial A. Neonatal sepsis bacterial isolates and antibiotic susceptibility patterns at a NICU in a tertiary care hospital in western part of Nepal: a retrospective analysis. Kathmandu Univ Med J. 2007;5:153–60.Google Scholar
  14. Khinchi YR, Kumar A, Yadhav S. Profile of neonatal sepsis. J Coll Med Sci. 2010;6:1–6.Google Scholar
  15. Shrestha S, Adjikari N, Shakya D, Manandhar L, Chand A. Bacteriological profile of neonatal blood cultures at Patan hospital. J Nep Pediatr Soc. 2007;26:1–4.Google Scholar
  16. Bhat YR, Lewis LE, Vandana KE. Bacterial isolates of early-onset neonatal sepsis and their antibiotic susceptibility pattern between 1998 and 2004: an audit from a center in India. Ital J Pediatr. 2011;37:32.View ArticleGoogle Scholar
  17. Begum S, Baki MA, Kundu GK, Islam I, Kumar M, Haque A. Bacteriological profile of neonatal sepsis in a tertiary hospital in Bangladesh. J Bangladesh Coll Phys Surg. 2012;30:66–70.Google Scholar
  18. Tröger B, Göpel W, Faust K, Müller T, Jorch G, Felderhoff-Müsser U, et al. Risk for late-onset blood-culture proven sepsis in very-low-birth weight infants born small for gestational age: a large multicenter study from the German Neonatal Network. Pediatr Infect Dis J. 2014;33:238–43.View ArticlePubMedGoogle Scholar
  19. Tsai MH, Hsu JF, Chu SM, Lien R, Huang HR, Chiang MC, et al. Incidence, clinical characteristics, and risk factors for adverse outcome in neonates with late onset sepsis. Pediatr Infect Dis J. 2014;33:e7–13.View ArticlePubMedGoogle Scholar
  20. Macdorman MF, Declercq E, Menacker F, Malloy MH. Infant and neonatal mortality for primary caesarean and vaginal births to women with “no indicated risk”, United States, 1998–2001 birth cohorts. Birth. 2006;33:175–82.View ArticlePubMedGoogle Scholar
  21. Kayenge N, Kamugisha E, Mwizamholya DL, Jeremiah S, Mshana SE. Predictors of positive blood culture and deaths among neonates with suspected neonatal sepsis in a tertiary hospital, Mwanza-Tanzania. BMC Pediatr. 2010;10:39.View ArticleGoogle Scholar
  22. Gyawali N, Sanjana RK. Bacteriological profile and antibiogram of neonatal septicaemia. Indian J Pediatr. 2013;80:371–4.View ArticlePubMedGoogle Scholar
  23. Shrestha R, Shrestha JM, Gurung B. Antibiotic usage and its sensitivity pattern in the NICU. Kathmandu Univ Med J. 2012;10:27–32.Google Scholar

Copyright

© The Author(s) 2018

Advertisement